Celltrion, Inc. Celltrion, Inc.

Celltrion, Inc.

068270

Classifica tra le azioni #720
Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the... Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the development and manufacturing of protein-based therapies, including treatments for oncology. Its commercial portfolio features established products such as Remsima, Truxima, and Herzuma, alongside a range of generic pharmaceuticals and diagnostic kits for COVID-19. The company maintains an extensive pipeline of antibody biosimilars currently undergoing various stages of clinical evaluation. Late-stage (Phase 3) candidates include CT-P17, aimed at rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease (IBD); CT-P16, targeting metastatic colorectal and breast cancers; CT-P43, for inflammatory conditions like psoriasis, Crohn's disease, and ulcerative colitis; CT-P42, addressing diabetic macular edema; and CT-P59, developed for COVID-19. In Phase 2, CT-P27 is being tested for pandemic and seasonal influenza. Earlier in development, Phase 1 assets comprise CT-P39 for asthma and urticaria, CT-P41 for osteoporosis and bone loss, and CT-G20 for cardiomyopathy. Additionally, Celltrion maintains a collaboration with Inhalon Biopharma, Inc. to advance IN-006, an inhaled formulation of regdanvimab intended for the treatment of COVID-19 patients. Established in 2002, the company operates primarily from its headquarters in Incheon, South Korea.
Prezzo delle azioni
$146.63
Capitalizzazione di mercato
$33.44B
Variazione (1 giorno)
-1.52%
Variazione (1 anno)
23.60%
Paese
KR
Scambia Celltrion, Inc. (068270)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Celltrion, Inc. (068270)
L’azione Celltrion, Inc. (simbolo: 068270) ha subito un totale di 17 frazionamenti.
L’ultimo frazionamento è avvenuto il Jun 04, 2026.
Una quota di 068270 acquistata prima di Aug 21, 2006 equivale oggi a 1.6182173250826 quote di 068270.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2026-06-04 21:20 x1.05 x1.6182173250826
2024-12-27 21:20 x1.05 x1.5411593572216
2022-12-28 26:25 x1.04 x1.4677708164015
2021-12-29 51:50 x1.02 x1.4113180926937
2020-12-29 51:50 x1.02 x1.3836451889154
2019-12-27 21:20 x1.05 x1.3565148910936
2018-12-27 51:50 x1.02 x1.2919189438986
2017-12-27 51:50 x1.02 x1.2665871999006
2016-12-28 21:20 x1.05 x1.2417521567653
2015-12-29 103:100 x1.03 x1.1826211016813
2014-12-29 21:20 x1.05 x1.148175826875
2013-12-27 103:100 x1.03 x1.0935007875
2013-03-04 1:2 x0.5 x1.06165125
2012-12-27 23:20 x1.15 x2.1233025
2012-05-24 3:2 x1.5 x1.84635
2006-09-28 1119:1000 x1.119 x1.2309
2006-08-21 11:10 x1.1 x1.1
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 1 x100
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL